Cove Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Cove Private Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$667K	Hold	11,575	–	–	0.13%	121
2026 Q1	$702K	Hold	11,575	–	–	0.16%	104
2025 Q4	$624K	Sell	11,575 -695	-6%	-$33.4K	0.19%	97
2025 Q3	$553K	Sell	12,270 -1,095	-8%	-$51.1K	0.18%	99
2025 Q2	$619K	Buy	13,365 +2,020	+18%	+$99.2K	0.22%	91
2025 Q1	$692K	Buy	11,345 +2,350	+26%	+$137K	0.36%	69
2024 Q4	$509K	Hold	8,995	–	–	0.31%	68
2024 Q3	$465K	Sell	8,995 -1,175	-12%	-$55.1K	0.36%	59
2024 Q2	$422K	Hold	10,170	–	–	0.34%	61
2024 Q1	$552K	Hold	10,170	–	–	0.47%	53
2023 Q4	$522K	Buy	+10,170	New	+$534K	0.49%	53

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cove Private Wealth's BMY Position: Q2 2026 in Review

Cove Private Wealth held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 11,575 shares worth $667K. The position accounts for 0.13% of the portfolio, ranked #121.

Cove Private Wealth first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $702K in Q1 2026. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cove Private Wealth held 11,575 shares of Bristol-Myers Squibb worth $667K as of Q2 2026.
Cove Private Wealth left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.13% of Cove Private Wealth's portfolio in Q2 2026, its #121 holding.
Cove Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
Cove Private Wealth's Bristol-Myers Squibb position peaked at $702K in Q1 2026.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.